Final CCGs submit applications

The final ‘wave’ of clinical commissioning groups have submitted their applications for authorisation with the NHS Commissioning Board (NHS CB).

Bridge over troubled healthcare

How will Public Health England bring together the NHS and local government?

CQC improving after difficult start

The Care Quality Commission has experienced “serious difficulties” in its first 18 months, according to a National Audit Office report.

NICE launches QOF consultation

The National Institute of Health and Clinical Excellence (NICE) has launched a public consultation on the new indicators for the 2013/14 Quality and Outcomes Framework (QOF).

Public ignoring flu jab

The Government has claimed people who ignore receiving the seasonal flu vaccine are playing “Russian roulette with their lives”.

New online register launched by EMA and ENCePP

The EMA and the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) have launched the E-Register of Studies.

The new UK pharma Code

Dr Powar asks how the changes to the ABPI Code will impact pharma's customer relationships.

What’s Up Doc?

With the advent of revalidation, doctors will be assessed for fitness to practice every five years. Dr Gerard Panting explains how the pharma industry...

Decoding The NHS

A Trust comprising of 3 hospitals were under considerable ‘bombardment’ from COX2 companies pushing considerable data and marketing materials. One company managed to involve...

The Supermarket of Private Primary Healthcare

The phrase “Healthcare is changing” is often heard within the NHS and today it is more relevant than ever in terms of diversity and...

Latest articles

focus on science and not geography

Greater global collaboration: Time to focus on science and not geography

The Pistoia Alliance is urging industry stakeholders worldwide to focus on science and not geography, in a call for greater global collaboration. More than 250...
Accelerating the MedTech landscape

Accelerating the MedTech landscape

The Academic Health Science Networks (AHSN) in partnership with the Association of British HealthTech Industries (ABHI) has launched a report on accelerating the MedTech...
Tescaro present data from the GARNET study on dostarlimab in endometrial cancer. 

Tescaro present data on dostarlimab in endometrial cancer

Tescaro release positive results from the GARNET study on dostarlimab in endometrial cancer.  TESARO, an oncology-focused business acquired by GlaxoSmithKline plc, presents data from the...

Popular articles

Bristol-Myers Squibb-Pfizer Alliance announces results from Phase 4 AUGUSTUS trial.

AUGUSTUS trial demonstrates favourable safety results

The Bristol-Myers Squibb-Pfizer Alliance has announced results from the Phase 4 AUGUSTUS trial evaluating Eliquis ® (apixaban) versus vitamin K antagonists (VKAs) in patients...
Smart phone image: Digital partnerships in pharma

Digital partnerships in pharma and the NHS

Can pharma and the NHS equal the fast pace of change necessary to fully embrace technological innovation? Over the last few years, slowly but surely,...
Trial results of Brilinta for heart attack patients following thrombolysis shows it met safety endpoint in secondary analysis of Phase III TREAT trial

Analysis of trial results of Brilinta for heart attack patients following thrombolysis

Analysis of trial results of Brilinta for heart attack patients following thrombolysis shows it met safety endpoint in secondary analysis of Phase III TREAT trial. The secondary...
The future of genomics

The future of genomics and precision medicine

How is the use of genomics data enhancing our medical understanding and what does this mean for the future of precision medicine? Genomics is one of...
Lixiana for Atrial Fibrillation

Daiichi Sanko announce results of two studies in the Edoxaban Clinical Research Programme

Daiichi Sankyo Company, Limited announces results from ELIMINATE-AF, a prospective, randomised, open label, blinded endpoint evaluation (PROBE) design study assessing the safety and efficacy...